Here is the latest shareholding Pattern of ORCHID PHARMA. For more details, see the ORCHID PHARMA financial fact sheet and ORCHID PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 89.96 | 89.96 | 89.96 | 89.96 | 72.40 | 72.40 | 69.84 | 69.84 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 89.96 | 89.96 | 89.96 | 89.96 | 72.40 | 72.40 | 69.84 | 69.84 | |
Mutual Funds | % | 2.45 | 2.45 | 2.45 | 2.45 | 9.78 | 9.76 | 10.40 | 15.18 | |
Financial institution/Banks/Insurance | % | 0.52 | 0.53 | 0.29 | 0.14 | 0.17 | 0.13 | 2.57 | 1.05 | |
Government | % | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 1.48 | 1.37 | 0.86 | 0.81 | 0.45 | 8.08 | 4.14 | 1.96 | |
Other | % | 0.00 | -0.00 | 1.20 | 0.03 | 11.67 | 2.58 | 1.53 | 1.50 | |
Total Institution | % | 4.49 | 4.35 | 4.80 | 3.43 | 22.07 | 20.55 | 18.64 | 19.69 | |
Bodies Corporate | % | 0.57 | 1.82 | 1.49 | 2.90 | 2.22 | 2.03 | 2.57 | 1.83 | |
Individuals | % | 3.69 | 3.61 | 3.43 | 3.39 | 3.10 | 3.85 | 7.79 | 7.44 | |
NRIs/OCBs | % | 0.05 | 0.06 | 0.05 | 0.05 | 0.06 | 0.16 | 0.28 | 0.37 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.24 | 0.19 | 0.26 | 0.26 | 0.15 | 1.02 | 0.89 | 0.83 | |
Total Non-Institution | % | 5.55 | 5.68 | 5.23 | 6.60 | 5.53 | 7.06 | 11.53 | 10.47 | |
Total Public | % | 10.00 | 10.00 | 10.00 | 10.00 | 28.00 | 28.00 | 30.00 | 30.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.